Financhill
Sell
9

OTRK Quote, Financials, Valuation and Earnings

Last price:
$1.45
Seasonality move :
-12.04%
Day range:
$1.44 - $1.48
52-week range:
$1.41 - $16.05
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.50x
P/B ratio:
0.53x
Volume:
24.7K
Avg. volume:
45.9K
1-year change:
-76.15%
Market cap:
$6.1M
Revenue:
$12.7M
EPS (TTM):
-$9.64
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $35.1M $82.8M $84.1M $14.5M $12.7M
Revenue Growth (YoY) 131.24% 136.04% 1.57% -82.75% -12.2%
 
Cost of Revenues $20.4M $43.6M $31.2M $7.5M $3.9M
Gross Profit $14.7M $39.2M $52.9M $7.1M $8.8M
Gross Profit Margin 41.85% 47.36% 62.9% 48.6% 69.06%
 
R&D Expenses $5.4M $12.9M $18.3M $11M $6.6M
Selling, General & Admin $29.3M $41.2M $53.7M $39.3M $22.8M
Other Inc / (Exp) -$2.6M -$1.2M -$10M -$4.4M -$123K
Operating Expenses $34.7M $54.2M $71.9M $50.2M $29.5M
Operating Income -$20M -$14.9M -$19M -$43.2M -$20.7M
 
Net Interest Expenses $3M $7.2M $8M $3.9M $7.2M
EBT. Incl. Unusual Items -$25.7M -$23.4M -$37M -$51.5M -$28M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -$645K $153K $88K -$80K
Net Income to Company -$25.7M -$22.7M -$37.1M -$51.6M -$27.9M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$25.7M -$22.7M -$37.1M -$51.6M -$27.9M
 
Basic EPS (Cont. Ops) -$140.40 -$129.60 -$222.30 -$234.15 -$49.50
Diluted EPS (Cont. Ops) -$140.40 -$129.60 -$222.30 -$234.15 -$49.50
Weighted Average Basic Share $182.4K $190.1K $207.3K $258.5K $743.9K
Weighted Average Diluted Share $182.4K $190.1K $207.3K $258.5K $743.9K
 
EBITDA -$21.8M -$14.2M -$25M -$42.4M -$14.4M
EBIT -$22.6M -$16.1M -$29M -$47.6M -$20.8M
 
Revenue (Reported) $35.1M $82.8M $84.1M $14.5M $12.7M
Operating Income (Reported) -$20M -$14.9M -$19M -$43.2M -$20.7M
Operating Income (Adjusted) -$22.6M -$16.1M -$29M -$47.6M -$20.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $24M $18.6M $2.8M $3.7M $2.6M
Revenue Growth (YoY) 171.59% -22.6% -84.71% 30.67% -30.85%
 
Cost of Revenues $13.1M $5.9M $1.4M $1M $975K
Gross Profit $11M $12.7M $1.4M $2.7M $1.6M
Gross Profit Margin 45.6% 68.51% 49.49% 72.01% 62.05%
 
R&D Expenses $3.7M $4.6M $2.8M $1.6M $1.2M
Selling, General & Admin $10.3M $13.6M $8.7M $5.2M $5.5M
Other Inc / (Exp) -$847K -$410K -$2.2M $38K $2K
Operating Expenses $14M $18.2M $11.5M $6.7M $6.7M
Operating Income -$3M -$5.4M -$10.1M -$4.1M -$5.1M
 
Net Interest Expenses $1.8M $2.1M $440K $2.4M $475K
EBT. Incl. Unusual Items -$5.7M -$7.9M -$12.7M -$6.4M -$5.6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- $20K -- --
Net Income to Company -$5.7M -$7.9M -$12.8M -$6.4M -$5.6M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$5.7M -$7.9M -$12.8M -$6.4M -$5.6M
 
Basic EPS (Cont. Ops) -$32.40 -$48.60 -$55.50 -$26.47 -$1.77
Diluted EPS (Cont. Ops) -$32.40 -$48.60 -$55.50 -$26.47 -$1.77
Weighted Average Basic Share $192K $210.2K $270.4K $327K $4.4M
Weighted Average Diluted Share $192K $210.2K $270.4K $327K $4.4M
 
EBITDA -$3.3M -$4.8M -$10.9M -$2.2M -$4.9M
EBIT -$3.9M -$5.8M -$12.3M -$4M -$5.1M
 
Revenue (Reported) $24M $18.6M $2.8M $3.7M $2.6M
Operating Income (Reported) -$3M -$5.4M -$10.1M -$4.1M -$5.1M
Operating Income (Adjusted) -$3.9M -$5.8M -$12.3M -$4M -$5.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $65.3M $103.1M $22.3M $11.7M $11.2M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $37.1M $40.6M $10.6M $3.7M $4M
Gross Profit $28.3M $62.5M $11.8M $8.1M $7.2M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- $18.4M $13.9M $6.6M $5.2M
Selling, General & Admin -- $55.8M $43.5M $24.9M $20.3M
Other Inc / (Exp) -$1.3M -$1M -$11.8M -$381K -$275K
Operating Expenses $48.4M $74.3M $57.3M $31.5M $25.5M
Operating Income -$20.1M -$11.8M -$45.6M -$23.5M -$18.4M
 
Net Interest Expenses $6.8M $8.2M $4.9M $6.9M $8.1M
EBT. Incl. Unusual Items -$28.2M -$21M -$62.2M -$30.8M -$26.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- $293K -$132K --
Net Income to Company -$28.2M -$20.3M -$62.5M -$30.6M -$26.7M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$28.2M -$20.3M -$62.5M -$30.6M -$26.7M
 
Basic EPS (Cont. Ops) -$153.00 -$142.20 -$303.75 -$125.77 -$9.64
Diluted EPS (Cont. Ops) -$153.00 -$142.20 -$303.75 -$125.77 -$9.64
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -$19.8M -$9.3M -$52M -$18M -$22.2M
EBIT -$21.3M -$12.8M -$57.3M -$23.8M -$24.5M
 
Revenue (Reported) $65.3M $103.1M $22.3M $11.7M $11.2M
Operating Income (Reported) -$20.1M -$11.8M -$45.6M -$23.5M -$18.4M
Operating Income (Adjusted) -$21.3M -$12.8M -$57.3M -$23.8M -$24.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $53.6M $73.8M $12M $9.2M $7.7M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $30.2M $27.1M $6.5M $2.7M $2.8M
Gross Profit $23.4M $46.7M $5.5M $6.5M $4.9M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $8M $13.5M $9.1M $4.7M $3.3M
Selling, General & Admin $28.5M $43.1M $31.6M $17.2M $14.7M
Other Inc / (Exp) -$1.2M -$1.1M -$4.1M -$133K -$285K
Operating Expenses $36.5M $56.6M $40.7M $22M $18M
Operating Income -$13.1M -$10M -$35.2M -$15.5M -$13.1M
 
Net Interest Expenses $5.2M $6.1M $3M $6M $6.9M
EBT. Incl. Unusual Items -$19.5M -$17.1M -$42.3M -$21.6M -$20.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- $140K -$80K --
Net Income to Company -$19.5M -$17.1M -$42.5M -$21.5M -$20.3M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$19.5M -$17.1M -$42.5M -$21.5M -$20.3M
 
Basic EPS (Cont. Ops) -$106.20 -$117.90 -$202.95 -$87.97 -$6.27
Diluted EPS (Cont. Ops) -$106.20 -$117.90 -$202.95 -$87.97 -$6.27
Weighted Average Basic Share $566.3K $607.7K $732.7K $965.2K $12.9M
Weighted Average Diluted Share $566.3K $607.7K $732.7K $965.2K $12.9M
 
EBITDA -$13.1M -$8.2M -$35.2M -$10.8M -$18.6M
EBIT -$14.3M -$11M -$39.3M -$15.6M -$19.3M
 
Revenue (Reported) $53.6M $73.8M $12M $9.2M $7.7M
Operating Income (Reported) -$13.1M -$10M -$35.2M -$15.5M -$13.1M
Operating Income (Adjusted) -$14.3M -$11M -$39.3M -$15.6M -$19.3M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $13.6M $86.9M $58.8M $5M $9.7M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $3.6M $16.7M $5.9M $973K --
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets $733K $4.1M $5M $3.2M $2.7M
Total Current Assets $20.4M $123.6M $80.3M $14.3M $12.8M
 
Property Plant And Equipment $2.9M $4.2M $4.4M $3.1M $1.1M
Long-Term Investments -- -- -- -- --
Goodwill -- $5.7M $5.7M $5.7M $5.7M
Other Intangibles -- $3.6M $2.3M $1.1M $99K
Other Long-Term Assets $520K $7.5M $850K $1.5M $147K
Total Assets $23.9M $144.7M $93.7M $25.8M $19.8M
 
Accounts Payable $1.4M $1.3M $1M $1.9M $563K
Accrued Expenses $2.2M $9M $6M $4.6M $2.8M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $374K $434K $595K $653K $56K
Other Current Liabilities $691K -- -- -- --
Total Current Liabilities $14.1M $36.4M $10.3M $9.5M $3.9M
 
Long-Term Debt $31.6M $45.7M $35.8M $10.1M $1.5M
Capital Leases -- -- -- -- --
Total Liabilities $47.8M $84M $48.1M $20.1M $5.6M
 
Common Stock $2K $2K $2K $3K $6K
Other Common Equity Adj -- -- -- -- --
Common Equity -$23.9M $60.8M $45.6M $5.7M $14.3M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -$23.9M $60.8M $45.6M $5.7M $14.3M
 
Total Liabilities and Equity $23.9M $144.7M $93.7M $25.8M $19.8M
Cash and Short Terms $13.6M $86.9M $58.8M $5M $9.7M
Total Debt $31.6M $45.7M $35.8M $10.1M $1.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $57.6M $75.3M $7.3M $3.2M $8M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $4.2M $5.2M $4.6M $212K $29K
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets $1.3M $2.7M $2.2M $2.7M $1.6M
Total Current Assets $74.1M $98.7M $19.1M $12.7M $10.2M
 
Property Plant And Equipment $3.9M $7.2M $3.2M $2M $667K
Long-Term Investments -- -- -- -- --
Goodwill -- $5.7M $5.7M $5.7M $5.7M
Other Intangibles -- $2.7M $1.4M $210K --
Other Long-Term Assets $5.1M $1.6M $1.2M $186K $5.9M
Total Assets $83.3M $115.8M $30.7M $20.8M $22.4M
 
Accounts Payable $1.5M $1.1M $1.8M $1.1M $490K
Accrued Expenses $3.3M $5.3M $2.7M $8.9M $1.6M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $418K $546K $655K $53K $65K
Other Current Liabilities $571K -- -- -- --
Total Current Liabilities $20.7M $15.9M $7.5M $11.2M $8.7M
 
Long-Term Debt $45.5M $46.4M $9.2M $14.1M $2.2M
Capital Leases -- -- -- -- --
Total Liabilities $68.2M $63.5M $17.5M $25.4M $10.9M
 
Common Stock $2K $2K $3K $3K $7K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity $45.5M -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $15.1M $52.3M $13.2M -$4.6M $11.5M
 
Total Liabilities and Equity $83.3M $115.8M $30.7M $20.8M $22.4M
Cash and Short Terms $57.6M $75.3M $7.3M $3.2M $8M
Total Debt $45.5M $46.4M $9.2M $14.1M $7.9M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$25.7M -$22.7M -$37.1M -$51.6M -$27.9M
Depreciation & Amoritzation $829K $1.9M $4M $5.2M $6.4M
Stock-Based Compensation $5.2M $8.1M $11.9M $7.5M $2.9M
Change in Accounts Receivable -$4.3M -$15.3M $11.9M $7.7M $687K
Change in Inventories -- -- -- -- --
Cash From Operations -$16.9M -$6.3M -$26.2M -$24M -$15.5M
 
Capital Expenditures -- $1.8M $4.5M $1.2M $285K
Cash Acquisitions -- -$2.9M -- -- --
Cash From Investing -- -$4.6M -$4.5M -$1.2M -$285K
 
Dividends Paid (Ex Special Dividend) -- -$1.2M -$9M -$2.2M --
Special Dividend Paid
Long-Term Debt Issued $46M $10M -- $11M $8M
Long-Term Debt Repaid -$16.9M -- -$10.8M -$39.5M -$134K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$4.8M -$2.1M -$3.3M -$4.4M $1.6M
Cash From Financing $27.3M $100.1M -$6.6M -$31.1M $15.8M
 
Beginning Cash (CF) $3.6M $14M $103.2M $65.9M $9.7M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $10.4M $89.2M -$37.3M -$56.2M -$12K
Ending Cash (CF) $14M $103.2M $65.9M $9.7M $9.7M
 
Levered Free Cash Flow -$16.9M -$8M -$30.6M -$25.1M -$15.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$5.7M -$7.9M -$12.8M -$6.4M -$5.6M
Depreciation & Amoritzation $510K $1M $1.4M $1.8M $171K
Stock-Based Compensation $1.8M $2.9M $1.2M $797K $1.7M
Change in Accounts Receivable -$2.8M -$88K -$653K $83K $856K
Change in Inventories -- -- -- -- --
Cash From Operations -$2.5M -$14.3M -$8.3M -$1.8M -$1.4M
 
Capital Expenditures $517K $1.4M $250K $73K $28K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$517K -$1.4M -$250K -$73K -$28K
 
Dividends Paid (Ex Special Dividend) -- -$2.3M -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $10M -- $11M -- $2.5M
Long-Term Debt Repaid -$45K -- -$7.5M -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$685K -$687K -$1.9M $1M -$386K
Cash From Financing $57.4M -$2.9M $5.6M $1M $2.1M
 
Beginning Cash (CF) $13.1M $103.2M $14.9M $10.1M $7.3M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $54.3M -$18.5M -$3M -$867K $674K
Ending Cash (CF) $67.4M $84.8M $11.9M $9.2M $8M
 
Levered Free Cash Flow -$3.1M -$15.6M -$8.6M -$1.9M -$1.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$28.2M -$20.3M -$62.5M -$30.6M -$26.7M
Depreciation & Amoritzation $1.5M $3.5M $5.3M $5.8M $2.4M
Stock-Based Compensation $8.1M $11.2M $9.3M $3.6M $3.1M
Change in Accounts Receivable -$4.2M -$1.9M $5.5M $4.4M -$444K
Change in Inventories -- -- -- -- --
Cash From Operations -$10.1M -$11.3M -$37.6M -$13.3M -$12.8M
 
Capital Expenditures $1.1M $4.5M $1.6M $348K $191K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$1.1M -$7.4M -$1.6M -$348K -$191K
 
Dividends Paid (Ex Special Dividend) -- -$8M -$4.5M -- --
Special Dividend Paid
Long-Term Debt Issued -- -- $11M $8M $7M
Long-Term Debt Repaid -$126K $126K -$50M -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -$3.6M -$5M $3.2M -$3.6M
Cash From Financing $62.3M $36.1M -$33.7M $11M $11.7M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $51.1M $17.4M -$72.8M -$2.7M -$1.3M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$11.2M -$15.8M -$39.2M -$13.7M -$12.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$19.5M -$17.1M -$42.5M -$21.5M -$20.3M
Depreciation & Amoritzation $1.3M $2.8M $4.2M $4.8M $788K
Stock-Based Compensation $5.8M $8.9M $6.3M $2.3M $2.5M
Change in Accounts Receivable -$2.8M $10.6M $4.2M $863K -$268K
Change in Inventories -- -- -- -- --
Cash From Operations -$6.1M -$11.1M -$22.5M -$11.9M -$9.1M
 
Capital Expenditures $1.1M $3.9M $1M $196K $102K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$1.1M -$3.9M -$1M -$196K -$102K
 
Dividends Paid (Ex Special Dividend) -- -$6.7M -$2.2M -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $10M -- $11M $8M $7M
Long-Term Debt Repaid -$126K -- -$39.2M -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$685K -$2.2M -$3.8M $3.7M -$1.5M
Cash From Financing $60.6M -$3.5M -$30.5M $11.6M $7.5M
 
Beginning Cash (CF) $39.5M $313M $113M $31.9M $23.4M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $53.4M -$18.4M -$54M -$486K -$1.7M
Ending Cash (CF) $92.9M $294.6M $59M $31.4M $21.7M
 
Levered Free Cash Flow -$7.2M -$15M -$23.5M -$12.1M -$9.2M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock